AIM ImmunoTech Inc. (AIM)

AMEX: AIM · Real-Time Price · USD

0.09

-0.03 (-23.53%)

At close: Apr 04, 2025, 10:10 AM

AIM ImmunoTech Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-17.32M	-28.96M	-19.45M	-19.13M	-14.4M	-9.53M	-9.81M	-8.26M	-7.5M
Depreciation & Amortization	246K	238K	256K	775K	733K	792K	878K	1.01M	1.3M
Stock-Based Compensation	686K	243K	954K	1.57M	1.04M	853K	929K	571K	410K
Other Working Capital	-828K	573K	787K	1.05M	654K	37K	-1.17M	591K	1.68M
Other Non-Cash Items	1.2M	310K	964K	4.24M	1.75M	255K	845K	-2.38M	-1.68M
Deferred Income Tax	n/a	5.84M	197K	-2.32M	-96K	-891K	-1.4M	-17K	57K
Change in Working Capital	296K	1.06M	966K	895K	605K	-543K	-2.08M	1.13M	29K
Operating Cash Flow	-14.89M	-21.27M	-16.11M	-13.96M	-10.37M	-9.07M	-10.64M	-7.94M	-7.38M
Capital Expenditures	-18K	-585K	-271K	-633K	-595K	-365K	-127K	-69K	-454K
Cash Acquisitions	n/a	47K	3.9M	592K	573K	n/a	755K	n/a	n/a
Purchase of Investments	-361K	-1.59M	-2.72M	-22.54M	-18.61M	-5.78M	-831K	n/a	n/a
Sales Maturities Of Investments	5.72M	1.3M	10.08M	22.29M	10.04M	n/a	-831K	2.8M	3.37M
Other Investing Acitivies	-631K	-585K	11.07M	-347K	-573K	-6.08M	1.13M	2.75M	3.08M
Investing Cash Flow	4.71M	-832K	10.99M	-631K	-9.16M	-6.15M	92K	2.73M	2.92M
Debt Repayment	2.25M	n/a	n/a	-4.85M	-4.68M	1.08M	4.92M	1.9M	-1K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.3M	485K	n/a	13.04M	61.25M	n/a	4.52M	-102K	4.76M
Financial Cash Flow	6.44M	485K	80K	8.19M	56.56M	16.39M	9.44M	4.21M	4.76M
Net Cash Flow	-3.74M	-21.61M	-5.04M	-6.41M	37.03M	1.17M	-1.11M	-996K	293K
Free Cash Flow	-14.91M	-21.85M	-16.38M	-14.6M	-10.96M	-9.43M	-10.77M	-8.01M	-7.83M

Advertisement

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Cash Flow Statement